Open AccessProgesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines
Author(s) -
Emma K. Grant,
Fatma A. Bucklain,
L. H. GINN,
Peter R. Laity,
Barbara Ciani,
Helen E. Bryant
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0268300
Subject(s) - gemcitabine , breast cancer , cancer research , progesterone receptor , cell culture , mifepristone , medicine , cancer , viability assay , biology , chemistry , oncology , estrogen receptor , pregnancy , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom